|

Therapeutic Recommendations for Nephroblastoma

RECRUITINGSponsored by French Africa Pediatric Oncology Group
Actively Recruiting
SponsorFrench Africa Pediatric Oncology Group
Started2020-07-01
Est. completion2028-12-31
Eligibility
Age6 Months – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04423484

Summary

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.

Eligibility

Age: 6 Months – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

Unilateral Nephroblastoma Tumor Not previously treated The general health of the child will permit treatment.

.

Exclusion Criteria:

Bilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the diagnosis Treatment Refusal

Conditions2

CancerNephroblastoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.